Coeptis Therapeutics Holdings (COEPW) Debt to Equity (2021 - 2025)
Historic Debt to Equity for Coeptis Therapeutics Holdings (COEPW) over the last 5 years, with Q3 2025 value amounting to $0.01.
- Coeptis Therapeutics Holdings' Debt to Equity fell 5436.0% to $0.01 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.01, marking a year-over-year decrease of 5436.0%. This contributed to the annual value of $0.31 for FY2024, which is 6718.7% up from last year.
- According to the latest figures from Q3 2025, Coeptis Therapeutics Holdings' Debt to Equity is $0.01, which was down 5436.0% from $0.02 recorded in Q2 2025.
- Over the past 5 years, Coeptis Therapeutics Holdings' Debt to Equity peaked at $0.7 during Q4 2021, and registered a low of -$0.13 during Q1 2024.
- In the last 5 years, Coeptis Therapeutics Holdings' Debt to Equity had a median value of $0.08 in 2023 and averaged $0.12.
- In the last 5 years, Coeptis Therapeutics Holdings' Debt to Equity skyrocketed by 44711.62% in 2023 and then tumbled by 17420.49% in 2024.
- Coeptis Therapeutics Holdings' Debt to Equity (Quarter) stood at $0.7 in 2021, then tumbled by 95.2% to $0.03 in 2022, then skyrocketed by 447.12% to $0.18 in 2023, then soared by 67.19% to $0.31 in 2024, then crashed by 95.54% to $0.01 in 2025.
- Its Debt to Equity was $0.01 in Q3 2025, compared to $0.02 in Q2 2025 and $0.11 in Q1 2025.